The results show that attachment to VCAM-1 reduces doxorubicin-induced apoptosis of Jurkat and HSB-2 cells by 32% and 21% respectively, suggesting that VCAM-1 induces resistance of T-ALL cells to doxorubicin (Figure 3A,B). This evidence concerns the gene VCAM1 and acute lymphoblastic leukemia.